Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|
July 1, 1997
Drug therapy for obesity: clarifications
T B Seaton
Annals of Internal Medicine
|
May 1, 1990
Tumor necrosis factor and hypermetabolism
T B Seaton, N Coombe, A Mittelman
The New England Journal of Medicine
|
April 18, 1985
Thermogenesis in brown adipose tissue
T B Seaton, S Welle, R G Campbell
Transactions of the American Clinical and Climatological Association
|
January 1, 1987
Specific dynamic action revisited: studies of hormonal regulation of energy expenditure in man
R G Campbell, S L Welle, T B Seaton
Archives of Internal Medicine
|
November 14, 1994
Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus
R F Coniff, J A Shapiro, T B Seaton
The New England Journal of Medicine
|
January 10, 1998
Obesity
T B Seaton, C M Mendel, S P Weinstein
The American Journal of Clinical Nutrition
|
December 1, 1986
Some metabolic effects of overeating in man
S L Welle, T B Seaton, R G Campbell
The American Journal of Medicine
|
May 1, 1995
Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus
R F Coniff, J A Shapiro, T B Seaton, et al.
The American Journal of Clinical Nutrition
|
November 1, 1986
Thermic effect of medium-chain and long-chain triglycerides in man
T B Seaton, S L Welle, M K Warenko, et al.
Diabetes Care
|
July 1, 1995
A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes
R F Coniff, J A Shapiro, T B Seaton, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|
July 1, 1997
Drug therapy for obesity: clarifications
T B Seaton
Annals of Internal Medicine
|
May 1, 1990
Tumor necrosis factor and hypermetabolism
T B Seaton, N Coombe, A Mittelman
The New England Journal of Medicine
|
April 18, 1985
Thermogenesis in brown adipose tissue
T B Seaton, S Welle, R G Campbell
Transactions of the American Clinical and Climatological Association
|
January 1, 1987
Specific dynamic action revisited: studies of hormonal regulation of energy expenditure in man
R G Campbell, S L Welle, T B Seaton
Archives of Internal Medicine
|
November 14, 1994
Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus
R F Coniff, J A Shapiro, T B Seaton
The New England Journal of Medicine
|
January 10, 1998
Obesity
T B Seaton, C M Mendel, S P Weinstein
The American Journal of Clinical Nutrition
|
December 1, 1986
Some metabolic effects of overeating in man
S L Welle, T B Seaton, R G Campbell
The American Journal of Medicine
|
May 1, 1995
Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus
R F Coniff, J A Shapiro, T B Seaton, et al.
The American Journal of Clinical Nutrition
|
November 1, 1986
Thermic effect of medium-chain and long-chain triglycerides in man
T B Seaton, S L Welle, M K Warenko, et al.
Diabetes Care
|
July 1, 1995
A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes
R F Coniff, J A Shapiro, T B Seaton, et al.
Page
of 2